Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery

Exclusion Criteria

• •Subjects undergoing emergency surgery
• •Parenchymal or anastomotic bleeding sites will not be considered for randomization
• •Subjects with any intra-operative findings identified by the surgeon that may preclude conduct of the study procedure
• •Subjects with known intolerance to blood products or to one for the components of the study product
• •Subjects unwilling to receive blood products
• •Subjects with known autoimmune immunodeficiency diseases (including known HIV
• •Subjects who are known, current alcohol and/or drug abusers
• •Subjects who have participated in another investigational drug or device research study within 30 days of enrollment
• •Female subjects who are pregnant or nursing